BSE Live
Mar 24, 16:01Prev. Close
2800.40
Open Price
2854.20
Bid Price (Qty.)
2862.50 (1)
Offer Price (Qty.)
2890.00 (10)
NSE Live
Mar 24, 15:59Prev. Close
2796.80
Open Price
2821.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Ajanta Pharma (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | -36.69 | 0.31 | |
| Diluted EPS (Rs.) | -36.69 | 0.31 | |
| Cash EPS (Rs.) | -31.67 | 6.08 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 85.88 | 146.26 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 85.88 | 146.26 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 148.64 | 99.76 | |
| PBDIT/Share (Rs.) | -29.49 | 15.22 | |
| PBIT/Share (Rs.) | -34.52 | 9.44 | |
| PBT/Share (Rs.) | -42.28 | 0.56 | |
| Net Profit/Share (Rs.) | -36.69 | 0.31 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | -19.83 | 15.25 | |
| PBIT Margin (%) | -23.22 | 9.46 | |
| PBT Margin (%) | -28.44 | 0.56 | |
| Net Profit Margin (%) | -24.68 | 0.30 | |
| Return on Networth / Equity (%) | -42.72 | 0.21 | |
| Return on Capital Employed (%) | -30.77 | 0.16 | |
| Return on Assets (%) | -21.17 | 0.14 | |
| Total Debt/Equity (X) | 0.79 | 0.35 | |
| Asset Turnover Ratio (%) | 85.80 | 45.34 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 2.03 | 3.08 | |
| Quick Ratio (X) | 1.08 | 1.94 | |
| Inventory Turnover Ratio (X) | 2.90 | 2.54 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 100.00 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 145.97 | 107.45 | |
| EV/Net Operating Revenue (X) | 0.83 | 0.91 | |
| EV/EBITDA (X) | -4.20 | 5.99 | |
| MarketCap/Net Operating Revenue (X) | 0.38 | 0.42 | |
| Retention Ratios (%) | 0.00 | 100.00 | |
| Price/BV (X) | 0.66 | 0.28 | |
| Price/Net Operating Revenue | 0.38 | 0.42 | |
| Earnings Yield | -0.64 | 0.01 |
16.03.2026
13.03.2026
06.02.2026
04.02.2026
03.02.2026
Ajanta Pharma Consolidated December 2025 Net Sales at Rs 1,374.84 crore, up 19.95% Y-o-Y
03.02.2026
Ajanta Pharma Standalone December 2025 Net Sales at Rs 1,206.59 crore, up 9.5% Y-o-Y
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct
25.03.2026
25.03.2026
24.03.2026
24.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth